The Vanguard Group 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 1:20 pm Unchanged |
2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
The Vanguard Group | 7,785,909 8.230% |
0 (Unchanged) |
Filing |
| 2024-11-04 11:16 am Purchase |
2024-09-30 | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN |
The Vanguard Group | 7,785,909 8.230% |
7,785,909 (New Position) |
Filing |